A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data

P Gimsing, Torben Plesner, H Nahi, H Lokhorst, M-L Valentin, S Lisby, PG Richardson

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato8. dec. 2011
StatusUdgivet - 8. dec. 2011
Begivenhed53th ASH Annual Meeting -
Varighed: 8. dec. 2011 → …

Konference

Konference53th ASH Annual Meeting
Periode08/12/2011 → …

Citer dette

Gimsing, P., Plesner, T., Nahi, H., Lokhorst, H., Valentin, M-L., Lisby, S., & Richardson, PG. (2011). A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data. Poster session præsenteret på 53th ASH Annual Meeting, .
Gimsing, P ; Plesner, Torben ; Nahi, H ; Lokhorst, H ; Valentin, M-L ; Lisby, S ; Richardson, PG. / A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data. Poster session præsenteret på 53th ASH Annual Meeting, .
@conference{c21ca370b58c4ae0a068edd33c7b9475,
title = "A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data",
author = "P Gimsing and Torben Plesner and H Nahi and H Lokhorst and M-L Valentin and S Lisby and PG Richardson",
year = "2011",
month = "12",
day = "8",
language = "English",
note = "null ; Conference date: 08-12-2011",

}

Gimsing, P, Plesner, T, Nahi, H, Lokhorst, H, Valentin, M-L, Lisby, S & Richardson, PG 2011, 'A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data', 53th ASH Annual Meeting, 08/12/2011.

A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data. / Gimsing, P; Plesner, Torben; Nahi, H; Lokhorst, H; Valentin, M-L; Lisby, S; Richardson, PG.

2011. Poster session præsenteret på 53th ASH Annual Meeting, .

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

TY - CONF

T1 - A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data

AU - Gimsing, P

AU - Plesner, Torben

AU - Nahi, H

AU - Lokhorst, H

AU - Valentin, M-L

AU - Lisby, S

AU - Richardson, PG

PY - 2011/12/8

Y1 - 2011/12/8

M3 - Poster

ER -

Gimsing P, Plesner T, Nahi H, Lokhorst H, Valentin M-L, Lisby S et al. A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data. 2011. Poster session præsenteret på 53th ASH Annual Meeting, .